Pharming (PHAR) Change in Receivables (2019 - 2025)
Pharming (PHAR) posted Change in Receivables of -$3.4 million for Q4 2025, up 50.54% on a QoQ basis from -$6.8 million in Q4 2024, and up 50.54% year-over-year from -$2.2 million in Q4 2024.
Pharming (PHAR) Change in Receivables (2019 - 2025) Analysis & Trends
Pharming's Change in Receivables history runs 7 years deep, the most recent figure standing at -$3.4 million for Q4 2025.
- Quarterly Change in Receivables rose 50.54% year-over-year to -$3.4 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$25.8 million (up 13.47% YoY) and the FY2025 annual result came in at -$3.4 million, up 50.54% from the prior year.
- Change in Receivables was -$3.4 million for Q4 2025 at Pharming, up from -$6.8 million in the prior quarter.
- Across five years, Change in Receivables topped out at $4.7 million in Q3 2021 and bottomed at -$18.5 million in Q4 2023.
- A 5-year average of -$2.8 million and a median of -$2.4 million in 2022 frame the typical range for Change in Receivables.
- Annual changes were most pronounced in 2021 — Change in Receivables soared 40409.31% — and 2023, when it sank 1168.06%.
- Pharming's Change in Receivables stood at $3.0 million in 2021, then plunged by 149.38% to -$1.5 million in 2022, then sank by 1168.06% to -$18.5 million in 2023, then surged by 63.41% to -$6.8 million in 2024, then soared by 50.54% to -$3.4 million in 2025.
- Business Quant data shows PHAR's Change in Receivables at -$3.4 million in Q4 2025, -$6.8 million in Q4 2024, and $2.9 million in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 75.30 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 2.84 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -39.80 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -1.20 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Pharming | 9.02 Bn | 8.96 Bn | 65.80 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -3.36 Mn |
| Dec 31, 2025 | -3.36 Mn |
| Dec 31, 2024 | -6.78 Mn |
| Dec 31, 2024 | -6.78 Mn |
| Sep 30, 2024 | 2.92 Mn |
| Sep 30, 2024 | 2.92 Mn |
| Dec 31, 2023 | -18.54 Mn |
| Dec 31, 2023 | -18.54 Mn |
| Sep 30, 2023 | -7.36 Mn |
| Sep 30, 2023 | -7.36 Mn |
| Jun 30, 2023 | -5.54 Mn |
| Jun 30, 2023 | -5.54 Mn |
| Dec 31, 2022 | -1.46 Mn |
| Dec 31, 2022 | -1.46 Mn |
| Sep 30, 2022 | 4.05 Mn |
| Sep 30, 2022 | 4.05 Mn |
| Dec 31, 2021 | 2.96 Mn |
| Dec 31, 2021 | 2.96 Mn |
| Sep 30, 2021 | 4.65 Mn |
| Sep 30, 2021 | 4.65 Mn |